000 01313 a2200325 4500
005 20250513095424.0
264 0 _c19961204
008 199612s 0 0 eng d
022 _a0278-5846
024 7 _a10.1016/0278-5846(96)00003-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBourin, M
245 0 0 _aA new design of trial for hypnotics comparison: a double-blind cross-over trial with patient's preference assessment and continuation of the preferred treatment.
_h[electronic resource]
260 _bProgress in neuro-psychopharmacology & biological psychiatry
_cApr 1996
300 _a373-85 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAnti-Anxiety Agents
_xtherapeutic use
650 0 4 _aBenzodiazepines
650 0 4 _aBenzodiazepinones
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSleep Initiation and Maintenance Disorders
_xdrug therapy
650 0 4 _aTriazolam
_xtherapeutic use
700 1 _aMalinge, M
773 0 _tProgress in neuro-psychopharmacology & biological psychiatry
_gvol. 20
_gno. 3
_gp. 373-85
856 4 0 _uhttps://doi.org/10.1016/0278-5846(96)00003-6
_zAvailable from publisher's website
999 _c8768390
_d8768390